In grafts in the absence of steatosis obtained from DBDs, we observed that the administration of exogenous NO (BD+NO+LT) increased IL-6 and that this was associated with reduced IL-1β levels and protection against hepatic damage and inflammation, compared to the BD+LT group (Figures 8–10). The gene discussed is IL1B; the disease is steatosis.